183 related articles for article (PubMed ID: 7872763)
1. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.
Doit CP; Bonacorsi SP; Fremaux AJ; Sissia G; Cohen R; Geslin PL; Bingen EH
Antimicrob Agents Chemother; 1994 Nov; 38(11):2655-9. PubMed ID: 7872763
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E
Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
Cormican MG; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
5. Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.
Fitoussi F; Doit C; Geslin P; Bingen E
Antimicrob Agents Chemother; 1999 Oct; 43(10):2372-5. PubMed ID: 10508009
[TBL] [Abstract][Full Text] [Related]
6. [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Barakett V; Lesage D; Delisle F; Guidet B; Burghoffer B; Richard G; Offenstadt G; Vergez P; Petit JC
Pathol Biol (Paris); 1992 May; 40(5):483-91. PubMed ID: 1495831
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
Tweardy DJ; Jacobs MR; Speck WT
J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
[TBL] [Abstract][Full Text] [Related]
8. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
[TBL] [Abstract][Full Text] [Related]
9. In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.
Schlegel L; Sissia G; Fremaux A; Geslin P
J Antimicrob Chemother; 1997 Jan; 39(1):95-8. PubMed ID: 9044034
[TBL] [Abstract][Full Text] [Related]
10. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.
Friedland IR; Paris M; Shelton S; McCracken GH
J Antimicrob Chemother; 1994 Aug; 34(2):231-7. PubMed ID: 7814283
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
[TBL] [Abstract][Full Text] [Related]
12. [A case of penicillin-resistant pneumococcal meningitis and antibiotic susceptibility of Streptococcus pneumoniae isolated from children].
Himi K; Miyamoto S; Ohshimi H; Kuroki H; Ishikawa N; Yamazaki T; Namba M; Suzuki H; Uehara S; Niimi H
Kansenshogaku Zasshi; 1990 Jun; 64(6):725-33. PubMed ID: 2401818
[TBL] [Abstract][Full Text] [Related]
13. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
14. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
15. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
[TBL] [Abstract][Full Text] [Related]
16. Comparative in-vitro activity of penicillin alone and combined with gentamicin against clinical isolates of Streptococcus pneumoniae with decreased susceptibility to penicillin.
Anadiotis L; Maskell JP; Sefton AM
Int J Antimicrob Agents; 2002 Mar; 19(3):173-81. PubMed ID: 11932138
[TBL] [Abstract][Full Text] [Related]
17. Killing kinetics of vancomycin and rifampin tested alone and in combination against penicillin-resistant Streptococcus pneumoniae.
Barakett V; Lesage D; Delisle F; Vergez P; Petit JC
Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):69-71. PubMed ID: 8462570
[No Abstract] [Full Text] [Related]
18. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci.
Gross ME; Giron KP; Septimus JD; Mason EO; Musher DM
Antimicrob Agents Chemother; 1995 May; 39(5):1166-8. PubMed ID: 7625807
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
